Experimental lung cancer vaccine lands Berkeley company potential $817M deal
October 16, 2014 at 08:53 AM EDT
Tiny Aduro BioTech Inc.’s experimental cancer vaccine has come up big again, landing a potential $817 million deal with Johnson & Johnson’s Janssen Biotech unit around lung cancer, the companies said Thursday...